France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 27, 2026

Apr. 27, 2026

All Wheels Up to Begin Offering CRO Training and Services to Air Carriers Large and Small

EIN Presswire

Apr. 27, 2026

JAECOO 5 SHS-H Completes 625 km Endurance Trial, Showcasing Hybrid Efficiency and Pet-Friendly Versatility

EIN Presswire

Apr. 27, 2026

Trade Unions and Italian Industry’s demands to Europe

EIN Presswire

Apr. 27, 2026

Influence Society Launches AI Studio to Scale Premium Content Production for Luxury Hospitality Brands

EIN Presswire

Apr. 27, 2026

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

GlobeNewswire

Apr. 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT

GlobeNewswire

Apr. 27, 2026

Fera Acquires 3Keel, Establishing a Unique Platform for End-to-End Support of the Life-Science Sector

EIN Presswire

Apr. 27, 2026

Nexans to acquire Republic Wire, establishing a strategic platform in the United States

GlobeNewswire

Apr. 27, 2026

Nexans signe un accord en vue de l’acquisition de Republic Wire et établit une plateforme stratégique aux États-Unis

GlobeNewswire

Apr. 27, 2026

AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors

GlobeNewswire

Apr. 27, 2026

AB Science annonce un accord final sur la renégociation des modalités de remboursement de ses emprunts avec l’ensemble de ses créanciers financiers

GlobeNewswire

Apr. 27, 2026

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients

GlobeNewswire

Apr. 27, 2026

Apollo Funds to Acquire Forvia’s Automotive Interiors Business

GlobeNewswire

Apr. 27, 2026

OSE Immunotherapeutics se félicite de l'octroi de la désignation de médicament orphelin par la FDA du pegrizeprument (VEL-101) pour la prévention du rejet d’organe dans la transplantation cardiaque

GlobeNewswire